Erectile dysfunction? Not this Valentine’s Day — there’s a spray for that

Erectile dysfunction could happen to anyone (well, almost anyone). But it doesn’t need to ruin your life or even be something ...

LifeRx Formally Launches Nationwide ED & Hair Loss Treatment Programs After Strong Early Traction

LifeRx, a trusted telehealth and wellness company specializing in metabolic, hormonal, cellular, performance, and men's ...
Everyday Health on MSN

Restoring intimacy: Navigating sexual dysfunction in schizophrenia and your treatment options

Sexual dysfunction is a common side effect of antipsychotics, but it doesn’t have to be permanent. Learn about causes, ...
Stockhead on MSN

StockTake: LTR Pharma starts recruitment for phase II trial of ED nasal spray

Host Tylah Tully looks at LTR Pharma's (ASX:LTP) latest clinical milestone, as the company kicks off patient recruitment for ...

Nicotine’s comeback is the latest wellness scam

Nicotine, the addictive drug present in tobacco, is having a moment — and not just as the pleasurable buzz most people seek ...

When Anthony began taking a popular hair loss drug, the side effects emerged almost immediately

As Gen Zs and Millennials turn to digital subscription services for hair loss, doctors are warning men to consult a GP in ...
Stockhead on MSN

Lunch Wrap: ASX chases miners as gold bursts above US$4600

In large cap news, Endeavour Group (ASX:EDV), the proud owner of Dan Murphy’s and BWS, sank 3% after the company flagged ...
Mid-Day

Dr. Saransh Jain featured as the Most Recommended Sexologist in Global TIME Magazine’s Person of the Year Edition

Dr. Saransh Jain featured in TIME Person of the Year Edition for ethical, science-driven sexual healthcare in India.
The Chosun Ilbo on MSN

Injection-pill combos and three-month shots intensify obesity treatment race

The "JP Morgan Healthcare Conference (JPMHC)," which publicly disclosed the research and development (R&D) status of global ...

Gavin Newsom Has Very Different Response to Tim Walz Over Fraud Allegations

While Walz issued press statements specifying the policy and administrative decisions he has made to tackle fraud, and has ...

Sustained Therapeutics Reports Positive Phase 2 Results for Its Long-Acting Non-Opioid Medication for Chronic Pain

Plans to seek regulatory approval to commence a Phase III trial in the US and Canada VANCOUVER, BC, Jan. 8, 2026 /PRNewswire/ -- Sustained Therapeutics Inc. ("Sustained Therapeutics" or the "Company") ...